Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report.

Autor: Nan D; Internal Medicine Department, University Hospital Marqués de Valdecilla, Santander, Spain.; University of Cantabria, Santander, Spain., Abraira-Meriel C; Dermatology Department, University Hospital Marqués de Valdecilla, Santander, Spain., de la Roz-Fernández S; Internal Medicine Department, University Hospital Marqués de Valdecilla, Santander, Spain., Maestre-Orozco T; Internal Medicine Department, University Hospital Marqués de Valdecilla, Santander, Spain., Hernandez JL; Internal Medicine Department, University Hospital Marqués de Valdecilla, Santander, Spain.; University of Cantabria, Santander, Spain., Fernandez-Ayala M; Internal Medicine Department, University Hospital Marqués de Valdecilla, Santander, Spain.

Publikováno v: European journal of case reports in internal medicine [Eur J Case Rep Intern Med] 2021 Oct 08; Vol. 8 (10), pp. 002821. Date of Electronic Publication: 2021 Oct 08 (Print Publication: 2021).